Runben Biotechnology Co Ltd

Runben Biotechnology Co Ltd has seen a significant surge in its shares and revenue due to the recent outbreak of the mosquito-borne disease Kyasanur Forest Disease, which has driven up demand for its mosquito repellent products.

Runben Biotechnology Co Ltd’s stock price has surged, reflecting a broader trend in the personal care sector, driven by increasing demand for health-centric consumer products.

Runben Biotechnology Co Ltd faces challenges in a competitive market, with its financial performance and market positioning warranting a closer look amidst broader market trends and investor sentiment.